The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide
- 175 Downloads
To the Editor,
A 75 year old woman presented in October of 2008 with new onset symptoms of headaches, difficulty with penmanship, forgetfulness and vertigo. Her past medical history includes sarcoidosis and osteoporosis. As a result of the sarcoidosis, she has chronic interstitial pulmonary fibrosis but refused treatment with chronic steroids. The physical exam was unremarkable and her Karnofsky performance status was 80. She was evaluated for vestibular abnormalities and a magnetic resonance imaging (MRI) with and without gadolinium was obtained. This demonstrated an enhancing extra-axial, dural-based mass in the high biparietal region, measuring 3.0 cm × 6.6 cm in the axial plane and encasing the superior sagittal sinus. This was initially thought to represent a meningioma.
KeywordsMultiple Myeloma Meningioma Sarcoidosis Lenalidomide Plasmacytoma
Conflict of interest
The authors declare no conflicts of interest.
- 1.Rajkumar S, Jacobus S, Callander N et al (2010) Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomized controlled trial. Lancet Oncol 11:29–37PubMedCentralPubMedCrossRefGoogle Scholar
- 3.Weber D (2005) Solitary bone and extramedullary plasmacytoma. Hematology, ASH Education Book, pp 373–376Google Scholar
- 5.Provenzale J, Schaefer P, Traweek S et al (1996) Craniocerebral plasmactyoma: MR features. Am J Neuroradiol 18:389–392Google Scholar